- Home
- CCM vs ANTX Comparison
CCM vs ANTX Comparison
Compare CCM & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCM
- ANTX
- Stock Information
- Founded
- CCM 1997
- ANTX 2017
- Country
- CCM China
- ANTX United States
- Employees
- CCM N/A
- ANTX N/A
- Industry
- CCM Medical/Nursing Services
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- CCM Health Care
- ANTX Health Care
- Exchange
- CCM Nasdaq
- ANTX Nasdaq
- Market Cap
- CCM 33.3M
- ANTX 33.2M
- IPO Year
- CCM 2009
- ANTX 2022
- Fundamental
- Price
- CCM $5.68
- ANTX $1.07
- Analyst Decision
- CCM
- ANTX Buy
- Analyst Count
- CCM 0
- ANTX 2
- Target Price
- CCM N/A
- ANTX $2.00
- AVG Volume (30 Days)
- CCM 2.5K
- ANTX 283.5K
- Earning Date
- CCM 04-25-2025
- ANTX 08-12-2025
- Dividend Yield
- CCM N/A
- ANTX N/A
- EPS Growth
- CCM N/A
- ANTX N/A
- EPS
- CCM N/A
- ANTX N/A
- Revenue
- CCM $52,603,198.00
- ANTX N/A
- Revenue This Year
- CCM N/A
- ANTX N/A
- Revenue Next Year
- CCM N/A
- ANTX N/A
- P/E Ratio
- CCM N/A
- ANTX N/A
- Revenue Growth
- CCM N/A
- ANTX N/A
- 52 Week Low
- CCM $3.80
- ANTX $0.87
- 52 Week High
- CCM $10.90
- ANTX $3.07
- Technical
- Relative Strength Index (RSI)
- CCM 38.23
- ANTX 42.04
- Support Level
- CCM $5.50
- ANTX $1.07
- Resistance Level
- CCM $5.95
- ANTX $1.11
- Average True Range (ATR)
- CCM 0.19
- ANTX 0.04
- MACD
- CCM 0.01
- ANTX 0.00
- Stochastic Oscillator
- CCM 39.74
- ANTX 0.00
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.